Bladder Cancer - Results from #560

REVIEW UroToday

Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer. February 26, 2024

A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial. February 26, 2024

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment. February 23, 2024

An in-depth analysis on the effects of body composition in patients receiving neoadjuvant chemotherapy for urothelial cell carcinoma. February 23, 2024

Molecular Biomarkers of Response to Trimodal Therapy in Bladder Cancer - Expert Commentary February 22, 2024

Quality of bladder cancer treatment information on YouTube: May the user's profile affect the quality of results? February 22, 2024

Current Trends and Challenges of Microbiome Research in Bladder Cancer. February 22, 2024

Response to 2 Induction Courses of Bacillus Calmette-Guèrin Therapy Among Patients With High-Risk Non-Muscle-Invasive Bladder Cancer: 5-year Follow-Up of a Phase 2 Clinical Trial. February 21, 2024

Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy. February 21, 2024

Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells. February 20, 2024

Symptomatic and functional recovery after transurethral resection of bladder tumor: Data from ecological momentary symptom assessment. February 20, 2024

Mini-Review: Current Bladder Cancer Treatment-The Need for Improvement. February 19, 2024

Experts' recommendations in laser use for the treatment of bladder cancer: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training and Research in Urological Surgery and Technology (TRUST)-Group. February 19, 2024

The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. February 16, 2024

Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics. February 16, 2024

Population Estimates of Ovarian Cancer Risk in a Cohort of Patients with Bladder Cancer. February 15, 2024

Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study. February 15, 2024

Advances in diagnosis and treatment of bladder cancer. February 14, 2024

Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a qualitative study exploring patient priorities and counselling needs when making a treatment choice. February 14, 2024

The role of URO17® in diagnosis and follow up of bladder cancer patients. February 13, 2024

Page 29 of 517